Jason P Rhodes insider trades

Open-market stock purchases and sales by Jason P Rhodes, Unknown at Dyne Therapeutics, Inc, from SEC Form 4 filings since Jul 1, 2013.

Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +18%.

Recent trades

DateStockTradeValue
Aug 14, 2026DYN Dyne Therapeutics, IncSold$34M
Aug 14, 2026DYN Dyne Therapeutics, IncSold$12M
Aug 14, 2026DYN Dyne Therapeutics, IncSold$8.1M
Aug 13, 2026DYN Dyne Therapeutics, IncSold$2.5M
Aug 13, 2026DYN Dyne Therapeutics, IncSold$1.7M
Aug 13, 2026DYN Dyne Therapeutics, IncSold$7M
Jul 7, 2026DYN Dyne Therapeutics, IncSold$1.1M
Jul 7, 2026DYN Dyne Therapeutics, IncSold$276K
Jul 7, 2026DYN Dyne Therapeutics, IncSold$118K
Jul 7, 2026DYN Dyne Therapeutics, IncSold$351K
Jul 7, 2026DYN Dyne Therapeutics, IncSold$2.9M
Jul 7, 2026DYN Dyne Therapeutics, IncSold$699K
Jul 7, 2026DYN Dyne Therapeutics, IncSold$1.4M
Jul 6, 2026DYN Dyne Therapeutics, IncSold$5.8M
Jul 6, 2026DYN Dyne Therapeutics, IncSold$2.9M
Jul 6, 2026DYN Dyne Therapeutics, IncSold$2.3M
Jun 29, 2026DYN Dyne Therapeutics, IncSold$2.2M
Jun 29, 2026DYN Dyne Therapeutics, IncSold$1.1M
Jun 29, 2026DYN Dyne Therapeutics, IncSold$860K
Jun 26, 2026DYN Dyne Therapeutics, IncSold$3.5M
Jun 26, 2026DYN Dyne Therapeutics, IncSold$1.7M
Jun 26, 2026DYN Dyne Therapeutics, IncSold$1.4M
Jun 25, 2026DYN Dyne Therapeutics, IncSold$268K
Jun 25, 2026DYN Dyne Therapeutics, IncSold$135K
Jun 25, 2026DYN Dyne Therapeutics, IncSold$106K

Companies traded

  • DYN Dyne Therapeutics, Inc: 1 buy, 114 sales, last Aug 14, 2026
  • GBIO Generation Bio Co: 41 sales, last Feb 9, 2026
  • REPL Replimune Group, Inc: 1 buy, 70 sales, last Apr 1, 2022
  • GMTX Gemini Therapeutics, Inc /DE: other filings, last Oct 4, 2021
  • EPZM Epizyme, Inc: 12 sales, last Sep 22, 2014

Get free alerts when Jason P Rhodes files a new trade →